Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AUTL stock hub

Autolus Therapeutics plc has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AUTLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

417.8M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

AUTL

In the news

Latest news · AUTL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-95

P25 -105.6P50 -46.5P75 -3.1

ROIC-27.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AUTL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

203

Groups with data

Currency

USD

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001730463
Company name	Autolus Therapeutics plc
Country	United Kingdom
Country code	US
Cusip	05280R100
Employees	754
Employees Change	104%
Employees Change Percent	16
Enterprise value	$458.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2018-06-22
Isin	US05280R1005
Last refreshed	2026-05-10
Market cap	$417.8M
Market cap category	Small-Cap
Price	$1.57
Price currency	USD
Rev Per Employee	99,984.08x
Sector	Healthcare
Sic	2836
Symbol	AUTL
Website	https://www.autolus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-68.81%
EV Sales Forward	3.53x
EV/Sales	6.08x
FCF yield	-72.42%
P/B ratio	2.35x
P/S ratio	5.54x
PS Forward	3.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-175.09%
Gross Profit	$-132M
Net Income	$-287.5M
Net Income Growth Years	0%
Pretax Margin	-378.78%
Profit Per Employee	$-381,337
ROA	-24.62
Roa5y	-24.2
ROCE	-52.4
ROE	-94.98
Roe5y	-76.29
ROIC	-27.14

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	27.66%
Cagr3y	-5.99%
Cagr5y	-21.81%
EPS Growth Years	0
Revenue Growth	644.94x
Revenue Growth Q	83,655.17x
Revenue Growth Quarters	1x
Revenue Growth Years	2x
Revenue Growth3 Y	128.01x
Revenue Growth5 Y	113.11x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.11
Assets	$589.1M
Cash	$300.7M
Current Assets	$435.9M
Current Liabilities	$73.4M
Debt	$341.6M
Debt Equity	$1.92
Equity	$178.1M
Interest Coverage	-6.38
Liabilities	$410.9M
Long Term Assets	$153.2M
Long Term Liabilities	$337.5M
Net Cash	$-40.9M
Net Cash By Market Cap	$-9.78
Net Debt Equity	$0.23
Tangible Book Value	$158.3M
Tangible Book Value Per Share	$0.59
WACC	12.57

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.94
Inventory Turnover	11.11
Net Working Capital	$66.3M
Quick ratio	5.13
Working Capital	$362.5M
Working Capital Turnover	$0.16

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.3%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	27.64%
200-day SMA	1.59
3Y total return	-16.93%
50-day SMA	1.49
50-day SMA vs 200-day SMA	50under200
5Y total return	-70.76%
All Time High	53.24
All Time High Change	-97.05%
All Time High Date	2018-11-09
All Time Low	1.11
All Time Low Change	42.08%
All Time Low Date	2025-04-11
ATR	0.09
Beta	1.93
Beta1y	1.89
Beta2y	1.45
Ch YTD	-21.11
High	1.64
High52	2.7
High52 Date	2025-07-24
High52ch	-41.85%
Low	1.55
Low52	1.18
Low52 Date	2026-03-27
Low52ch	33.62%
Ma50ch	5.51%
Premarket Change Percent	1.86
Premarket Price	$1.64
Premarket Volume	46,339
Price vs 200-day SMA	-1.07%
RSI	53.76
RSI Monthly	43
RSI Weekly	50.81
Sharpe ratio	0.65x
Sortino ratio	1.08
Total Return	-4.3%
Tr YTD	-21.11
Tr1m	15.44%
Tr1w	6.8%
Tr3m	10.56%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	1
Analyst Price Target Top	$10
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.27
Earnings Revenue Estimate	26,160,088x
Earnings Revenue Estimate Growth	191.25x
Operating Income	$-270.2M
Operating margin	-358.4
Price target	$8.5
Price Target Change	$441
Price Target Change Top	$537

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	84,215,773%
Float Percent	31.64%
Shares Insiders	6.12%
Shares Institutions	20.64%
Shares Out	266,143,286
Shares Qo Q	0%
Shares Yo Y	4.3%
Short Ratio	8.13
Short Shares	8.23

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-317M
Average Volume	1,323,551.45x
Bv Per Share	0.67
CAPEX	$-19M
Ch1m	15.44
Ch1w	6.8
Ch1y	27.64
Ch3m	10.56
Ch3y	-16.93
Ch5y	-70.76
Ch6m	18.05
Change	-2.48%
Change From Open	-3.09
Close	1.61
Days Gap	0.62
Depreciation Amortization	9,814,000
Dollar Volume	1,890,827.9
Earnings Date	2026-05-14
Earnings Time	bmo
EBIT	$-270.2M
EBITDA	$-260.4M
EPS	$-1.08
F Score	3
FCF	$-302.6M
FCF EV Yield	-65.97x
FCF Per Share	$-1.14
Financing CF	-4,339,000
Fiscal Year End	December
Founded	2,014
Income Tax	$2M
Investing CF	158,458,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-27
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-27
Ma150	1.52
Ma150ch	3.15%
Ma20	1.53
Ma20ch	2.48%
Net CF	-123,170,000
Next Earnings Date	2026-05-14
Open	1.62
Optionable	Yes
Position In Range	22.22
Post Close	1.57
Postmarket Change Percent	3.82
Postmarket Price	$1.63
Ppne	128,503,000
Pre Close	1.61
Price Date	2026-05-08
Ptbv Ratio	2.64
Relative Volume	0.91x
Revenue	75,388,000x
SBC By Revenue	19.15x
Share Based Comp	14,438,000
Tax By Revenue	2.62x
Tr6m	18.05%
Volume	1,204,349
Z Score	-3.25

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AUTL pay a dividend?

Capital-return profile for this ticker.

Performance

AUTL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AUTL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+20.6%

Float: +31.6% of shares outstanding

Insider ownership

+6.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

AUTL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.8

Neutral momentum band

Price vs 200-day MA

-1.1%

50/200-day relationship not available

Beta (5Y)

1.93

More volatile than the market

Sharpe ratio

0.65

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AUTL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current AUTL stock rating?

Autolus Therapeutics plc is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full AUTL analysis?

The full report lives at /stocks/AUTL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for AUTL?

The latest report frames AUTL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the AUTL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.